Exelixis, Inc. v. MSN Laboratories Private Limited et al
| Exelixis, Inc. |
| MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc. |
| 1:2022cv00945 |
| July 18, 2022 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 23, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 12
SO ORDERED Granting (D.I. 34 in 22-cv-228-RGA-JLH; D.I. 11 in 22-cv-945-RGA) Stipulation and Proposed Order to Consolidate Action. Signed by Judge Richard G. Andrews on 8/23/2022. Associated Cases: 1:22-cv-00228-RGA-JLH, 1:22-cv-00945-RGA(nms)
|
| Filing 11 STIPULATION and [Proposed] Order to Consolidate Action by Exelixis, Inc.. (Raucci, Anthony) |
| Filing 10 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent MSN Laboratories Private Limited for MSN Pharmaceuticals, Inc. filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc.. (Gattuso, Dominick) |
| Filing 9 ANSWER to #1 Complaint, and COUNTERCLAIMS against All Plaintiffs, by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Gattuso, Dominick) Modified on 8/10/2022 (nms). |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Filing 8 SUMMONS Returned Executed by Exelixis, Inc.. MSN Pharmaceuticals, Inc. served on 7/19/2022, answer due 8/9/2022. (Raucci, Anthony) |
| Filing 7 SUMMONS Returned Executed by Exelixis, Inc.. MSN Laboratories Private Limited served on 7/19/2022, answer due 8/9/2022. (Raucci, Anthony) |
| Filing 6 Summons Issued as to MSN Laboratories Private Limited on 7/18/2022; MSN Pharmaceuticals, Inc. on 7/18/2022. (Attachments: #1 Summons Issued MSN Laboratories Private Limited)(smg) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Exelixis, Inc. (smg) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,298,349 B2. (smg) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: On or about June 7, 2022. Date of Expiration of Patent: 02/10/2032. (smg) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (smg) |
| Filing 1 COMPLAINT for PATENT INFRINGEMENT - filed against MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-3917357.) - filed by Exelixis, Inc. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(smg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
